SHORT MINI-FUTURE - PFIZER INC | Delayed Deutsche Boerse AG 18:54:48 15/05/2024 BST | ||
| 3.42 EUR | -2.29% |
|
| Current month | -8.62% | ||
| 1 month | -7.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 15/05/24 | 3.42 | -2.29% |
| 14/05/24 | 3.5 | 0.00% |
| 13/05/24 | 3.5 | -1.13% |
| 10/05/24 | 3.54 | +0.28% |
| 09/05/24 | 3.53 | -1.12% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 06:54 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VX4VZJ |
| ISIN | DE000VX4VZJ1 |
| Date issued | 17/12/2021 |
| Strike | 66.11 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.87 € |
|---|---|
| Lowest since issue | 0.76 € |
| Spread | 0.01 € |
| Spread % | 0.29% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.38
USD
Average target price
31.94
USD
Spread / Average Target
+12.54%
- Stock Market
- Certificates
- Certificat
